Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   
Browse
Conferences
Browse
< Back to conference highlights
Subscribe
Bookmark and Share

ASH 2016

3rd - 6th Dec 2016

Videos

News

06.12.16

ASH 2016: Multiple myeloma highlights

06.12.16

Interim results from the ZUMA-1 trial of novel CAR-T cells...

06.12.16

Pacritinib versus best available therapy for low platelet...

06.12.16

Dose escalation of CPI-613 with bendamustine for relapsed T...

06.12.16

DVd vs Vd for relapsed or refractory myeloma: CASTOR trial...

06.12.16

ASH 2016 highlights: breaking new ground in haematology

06.12.16

TCA cycle inhibition by CPI-613 increases chemo sensitivity...

06.12.16

Azacitidine plus nivolumab against acute myeloid leukaemia

05.12.16

IKZF1 mutations associated with paediatric ALL

05.12.16

Rituximab after ASCT prolongs survival for young MCL...

05.12.16

How can we use crenolanib to treat AML?

05.12.16

Highlights in myeloid leukaemia research from ASH 2016

05.12.16

Thromboembolytic risks of central venous catheters in...

05.12.16

Pure erythroid leukaemias

05.12.16

Clinical updates for guadecitabine and vorinostat

05.12.16

ALL: Combining paediatric-type therapy with minimal residual...

05.12.16

Pracinostat and azacitidine for elderly AML

05.12.16

ASH 2016: AML, CLL and leukaemogenesis latest

05.12.16

Advances in CLL from ASH 2016

05.12.16

Ineligibility required for 'anti-trials': inclusion in...

05.12.16

Vosaroxin for relapsed AML: Updates from VALOR

04.12.16

Impact of next-generation sequencing on treatment choice for...

04.12.16

Obinutuzumab extends PFS for follicular lymphoma in GALLIUM...

04.12.16

Venetoclax plus cytarabine in elderly AML patients

04.12.16

Intravenous or subcutaenous rituximab for FL in the SABRINA...

04.12.16

Ibrutinib in CLL: RESONATE and resistance

04.12.16

Large granular lymphocyte proliferations in MDS

04.12.16

Durable remissions with the VcR-CVAD regimen for MCL...

03.12.16

Tailoring therapy for leukaemia patients

03.12.16

TKI cessation for CML patients with deep molecular response:...

03.12.16

Dose reduction of TKIs for CML patients with deep molecular...

03.12.16

Updates from the EURO-SKI trial of tyrosine kinase cessation

03.12.16

Incidence and risk factors for central venous catheter...

03.12.16

CML patients with stable response may safely decrease dose...

03.12.16

Novel antibody boosts responses in newly diagnosed AML

03.12.16

Vadastuximab talirine in combination for newly diagnosed AML

03.12.16

Remissions following anti-CD22 CAR therapy in children with...

03.12.16

Subgroup analysis of elderly high risk AML patients...

03.12.16

A new spin on leukaemia therapy

03.12.16

Anti CD22 CAR T cell therapy for relapsed paediatric ALL

03.12.16

CPX-351 after stem cell transplant for elderly patients with...

Conferences Calendar

Information on upcoming conferences > find out where ecancer is filming next sign up for coverage submit your event

Previous conferences: highlights



Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation